Product Categories
| Country: | China |
|---|---|
| Tel: | 400-025 |
| Mobile: | +86 |
| E-mail: | Adooqname@qq.com |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| RAD140 | C20H16ClN5O2 | 1182367-47-0 | Details |
| CNX-1351 | C30H35N7O3S | 1276105-89-5 | Details |
| Namitecan | C23H22N4O5 | 372105-27-6 | Details |
| Transcrocetinate disodium | C20H25NaO4 | 591230-99-8 | Details |
| Necrostatin 2 racemate | C13H12ClN3O2 | 852391-15-2 | Details |
| Bismuth Subcitrate Potassium | C6H9BiKO7 | 880149-29-1 | Details |
| AEZS-108 | C91H117N19O26 | 139570-93-7 | Details |
| LP-261 | C22H19N3O4S | 915412-67-8 | Details |
| Ilorasertib | C25H21FN6O2S | 1227939-82-3 | Details |
| Spautin-1 | C15H11F2N3 | 1262888-28-7 | Details |
| Aureusimine B | C14H16N2O | 170713-71-0 | Details |
| Aprocitentan | C16H14Br2N6O4S | 1103522-45-7 | Details |
| ERB-196 | C17H10FNO2 | 550997-55-2 | Details |
| IPSU | C23H27N5O2 | 1373765-19-5 | Details |
| FTI 277 | C22H29N3O3S2 | 170006-73-2 | Details |
| SR3335 | C13H9F6NO3S2 | 293753-05-6 | Details |
| Ibodutant (MEN 15596) | C37H48N4O4S | 522664-63-7 | Details |
| ELR510444 | C19H16N2O2S2 | 1233948-35-0 | Details |
| Selinexor (KPT-330) | C17H11F6N7O | 1393477-72-9 | Details |
| AL082D06 | C23H24ClN3O2 | 256925-03-8 | Details |
| NS11394 | C23H19N3O | 951650-22-9 | Details |
| SR9011 | C23H31ClN4O3S | 1379686-29-9 | Details |
| MI-773 (SAR405838) | C29H34Cl2FN3O3 | 1303607-07-9 | Details |
| Alisporivir | C63H113N11O12 | 254435-95-5 | Details |
| Hoechst 33258 analog 3 | C26H26N6 | 23554-98-5 | Details |
| MS436 | C18H17N5O3S | 1395084-25-9 | Details |
| CCT241736 | C22H23Cl2N7 | 1402709-93-6 | Details |
| SJB3-019A | C16H8N2O3 | 2070015-29-9 | Details |
| JAK-IN-1 | C20H24N6O2 | 1334673-53-8 | Details |
| TTA-Q6 | C20H15ClF3N3O | 910484-28-5 | Details |
| KU 0060648 | C33H34N4O4S | 881375-00-4 | Details |
| (Z)-SMI-4a | C11H6F3NO2S | 327033-36-3 | Details |
| K02288 | C20H20N2O4 | 1431985-92-0 | Details |
| LY 344864 S-enantiomer | C21H22FN3O | 186544-27-4 | Details |
| 8-Oxocoptisine | C19H13NO5 | 19716-61-1 | Details |
| GKA50 | C26H28N2O6 | 851884-87-2 | Details |
| MDR-1339 | C20H22O4 | 1018946-38-7 | Details |
| B-Raf-inhibitor 1 | C26H19ClN8 | 1093100-40-3 | Details |
| TMP 195 | C23H19F3N4O3 | 1314891-22-9 | Details |
| GSK2838232 | C48H73ClN2O6 | 1443461-21-9 | Details |
| LuAE58054 | C20H20ClF5N2O | 467458-02-2 | Details |
| Teneligliptin hydrobromide | C22H31BrN6OS | 906093-29-6 | Details |
| NVP-LCQ195 | C17H19Cl2N5O4S | 902156-99-4 | Details |
| CK-636 | C16H16N2OS | 442632-72-6 | Details |
| CX-6258 | C26H24ClN3O3 | 1202916-90-2 | Details |
| HOE 32020 | C25H23ClN6 | 23554-99-6 | Details |
| RU-SKI 43 | C22H30N2O2S | 1043797-53-0 | Details |
| P005091 | C12H7Cl2NO3S2 | 882257-11-6 | Details |
| Aticaprant | C26H27FN2O2 | 1174130-61-0 | Details |
| Spebrutinib besylate (AVL-292 benzenesulfonate) | C28H28FN5O6S | 1360053-81-1 | Details |
| PF-543 Citrate | C33H39NO11S | 1415562-83-2 | Details |
| JI-101 | C22H20BrN5O2 | 900573-88-8 | Details |
| LY2090314 | C28H25FN6O3 | 603288-22-8 | Details |
| IKK-IN-1 | C22H26ClN3O4 | 406211-06-1 | Details |
| AZD5363 | C21H25ClN6O2 | 1143532-39-1 | Details |
| TCS ERK 11e (VX-11e) | C24H20Cl2FN5O2 | 896720-20-0 | Details |
| CP 316311 | C21H29NO2 | 175139-41-0 | Details |
| LDN-212854 | C25H22N6 | 1432597-26-6 | Details |
| SNT-207858 | C32H45Cl4N5O3 | 1104080-42-3 | Details |
| Rolapitant | C25H26F6N2O2 | 552292-08-7 | Details |
| CC-930 (Tanzisertib) | C21H23F3N6O2 | 899805-25-5 | Details |
| OG-L002 | C15H15NO | 1357302-64-7 | Details |
| Temsavir (BMS 626529) | C24H23N7O4 | 701213-36-7 | Details |
| UNC0642 | C29H44F2N6O2 | 1481677-78-4 | Details |
| FRAX597 | C29H28ClN7OS | 1286739-19-2 | Details |
| Nucleoside-Analog-1 | C9H9N5O5 | 876707-99-2 | Details |
| GW841819X | C25H21N5O2 | 146135-18-4 | Details |
| BI-9627 | C16H19F3N4O2 | 1204329-34-9 | Details |
| OTSSP167 | C25H28Cl2N4O2 | 1431697-89-0 | Details |
| BI605906 | C17H22F2N4O3S2 | 960293-88-3 | Details |
| Crizotinib hydrochloride | C21H23Cl3FN5O | 1415560-69-8 | Details |
| 4-Acetamidobutanoic acid | C6H11NO3 | 3025-96-5 | Details |
| PLpro inhibitor | C22H22N2O2 | 1093070-14-4 | Details |
| DIM-C-pPhOH | C23H18N2O | 151358-47-3 | Details |
| CEP-32496 | C24H22F3N5O5 | 1188910-76-0 | Details |
| Senexin A | C17H14N4 | 1366002-50-7 | Details |
| Birinapant (TL32711) | C42H56F2N8O6 | 1260251-31-7 | Details |
| GENZ-644282 | C22H21N3O5 | 529488-28-6 | Details |
| PSI-697 | C21H18ClNO3 | 851546-61-7 | Details |
| GSK221149A (Retosiban) | C27H34N4O5 | 820957-38-8 | Details |
| PCI 29732 | C22H21N5O | 330786-25-9 | Details |
| Amisulpride hydrochloride | C17H28ClN3O4S | 81342-13-4 | Details |
| D-erythro-Sphingosine | C18H37NO2 | 123-78-4 | Details |
| Flumatinib mesylate | C30H33F3N8O4S | 895519-91-2 | Details |
| Amadacycline methanesulfonate | C29H40N4O7.x(CH4O3S) | 1196800-40-4 | Details |
| AGN 195183 | C22H22ClF2NO4 | 367273-07-2 | Details |
| Valecobulin | C26H28N6O5S | 1188371-47-2 | Details |
| CaMKII-IN-1 | C29H30ClN5O2S | 1208123-85-6 | Details |
| ML213 | C17H23NO | 489402-47-3 | Details |
| BMS-687453 | C22H21ClN2O6 | 1000998-59-3 | Details |
| STF-31 | C23H25N3O3S | 724741-75-7 | Details |
| ML-323 | C23H24N6 | 1572414-83-5 | Details |
| LY-900009 | C23H27N3O4 | 209984-68-9 | Details |
| LY2452473 | C22H22N4O2 | 1029692-15-6 | Details |
| ALK-IN-1 (Brigatinib analog, AP26113 analog) | C26H34ClN6O2P | 1197958-12-5 | Details |
| B-Raf inhibitor 1 dihydrochloride | C26H21Cl3N8 | 1191385-19-9 | Details |
| Flumequine | C14H12FNO3 | 42835-25-6 | Details |
| GSK-269984A | C20H15Cl2FNNaO3 | 892664-04-9 | Details |
| SF1670 | C19H17NO3 | 345630-40-2 | Details |
| Spliceostatin A | C28H43NO8 | 391611-36-2 | Details |
| Product Total： Product Page： | ||||
| 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 | ||||